The 80th Annual Meeting of the Japanese Society of Hematology

Presentation information

Print

Oral Session

Oral Session 1-10B Treatment of MM: Immunomodulatory drugs etc

Fri. Oct 12, 2018 10:10 AM - 11:10 AM No.10 (Osaka International Convention Center, 10F 1009)

Chair: Reiko Nakaseko (Saitama medical center. Saitama Medical University, Japan)

[OS1-10B-1] Elotuzumab plus lenalidomide/dexamethasone prolongs survival duration of RRMM patients

Yutaka Okuno1, Yawara Kawano1, Shikiko Ueno1, Hiroyuki Hata2, Masao Matsuoka1 (1.Departments of Hematology, Kumamoto University Graduate School of Medicine, 2.Division of Informative Clinical Sciences, Kumamoto University)

Abstract password authentication.
Password is written on a program and abstract book.

Password